News

Mylan fourth quarter profit falls on costs

The Associated Press
By The Associated Press
1 Min Read Feb. 24, 2011 | 15 years Ago
Go Ad-Free today

The Canonsburg-based company reported net income of $2.6 million, or a penny per share, for the three months ended Dec. 31, down from $4.1 million, or a penny per share, a year ago. The most recent quarter included an additional 67.5 million shares of common stock outstanding.

Revenue rose 6 percent to $1.43 billion from $1.35 billion.

Excluding charges, including purchase accounting items and litigation expenses, the company said it earned 45 cents per share. Analysts polled by FactSet expected adjusted earnings per share of 45 cents and revenue of about $1.46 billion.

Operating expenses rose 6 percent to $485 million while interest expense rose 17 percent to $91.5 million.

For the full year, the company had net income of $223.5 million, or 68 cents per share, compared with $93.5 million, or 30 cents per share, in 2009. Revenue rose to $5.45 billion from $5.09 billion.

Looking ahead, the company expects 2011 profit between $1.90 and $2.10 per share on revenue between $6.1 billion and $6.4 billion. Analysts expect profit of about $1.99 per share on revenue of about $6.05 billion.

Generic drug maker Mylan Inc. said Thursday that its fourth-quarter profit fell 38 percent on higher costs and charges, but adjusted results meet Wall Street expectations.

Share

About the Writers

Push Notifications

Get news alerts first, right in your browser.

Enable Notifications

Enjoy TribLIVE, Uninterrupted.

Support our journalism and get an ad-free experience on all your devices.

  • TribLIVE AdFree Monthly

    • Unlimited ad-free articles
    • Pay just $4.99 for your first month
  • TribLIVE AdFree Annually BEST VALUE

    • Unlimited ad-free articles
    • Billed annually, $49.99 for the first year
    • Save 50% on your first year
Get Ad-Free Access Now View other subscription options